NCT00808392View on ClinicalTrials.gov

Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

PHASE3CompletedINTERVENTIONAL
Enrollment

916

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Haemophilus Influenzae Type b
Interventions
BIOLOGICAL

Haemophilus influenzae type b vaccine

3 doses one month apart of Monovalent conjugated vaccine against Haemophilus influenzae type b vaccine

BIOLOGICAL

Commercial Haemophilus influenzae type b vaccine

3 doses one month apart of Haemophilus influenzae type b vaccine.

Trial Locations (2)

072650

the CDC of Dingxing county(site no 02), Dingxing

050800

The CDC of Zhengding county(site no 01), Zhengding

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY